Atlas Trials

Jansky-Bielschowsky Disease

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Jansky-Bielschowsky Disease

RecordFirmDate
A Safety, Tolerability, and Efficacy Study of BMN 190 in Pediatric Patients < 18 Years of Age With CLN2 Disease (NCT02678689)BioMarin Pharmaceutical2016-01-22
An Extension Study to Evaluate the Long-Term Efficacy and Safety of BMN 190 in Patients With CLN2 Disease (NCT02485899)BioMarin Pharmaceutical2015-02-01
A Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Intracerebroventricular BMN 190 in Patients With Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN2) Disease (NCT01907087)BioMarin Pharmaceutical2013-09-01

Track Jansky-Bielschowsky Disease automatically

Every clearance here is in the API, with alerts when new ones post.